Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Offringa

Showing results (221-230 of 248) with videos related to

Pageof 25
Sort By:
Journal of Clinical Epidemiology|May 10, 2026
Updating the PRISMA reporting guideline for scoping reviews: a scoping reviewAndrea C Tricco, Emily Robinson, Sharon E Straus, et al.
BMJ (Clinical Research Ed.)|February 24, 2026
CONSORT-C 2026 explanation and elaboration: recommendations for enhancing the reporting and impact of paediatric randomised trialsAmi Baba, Maureen Smith, Beth K Potter, et al.
BMJ (Clinical Research Ed.)|February 24, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
JAMA Pediatrics|February 24, 2026
CONSORT-Children and Adolescents (CONSORT-C) 2026 Extension Statement: Enhancing the Reporting and Impact of Pediatric Randomized TrialsAmi Baba, Maureen Smith, Beth K Potter, et al.
Plos One|June 14, 2014
The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial--BARTrialChristian V Hulzebos, Peter H Dijk, Deirdre E van Imhoff, et al.
The Lancet. Child & Adolescent Health|June 12, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
The New England Journal of Medicine|February 6, 2020
Lower versus Traditional Treatment Threshold for Neonatal HypoglycemiaAnne A M W van Kempen, P Frank Eskes, Debbie H G M Nuytemans, et al.
BMJ (Clinical Research Ed.)|February 24, 2026
SPIRIT-C 2026 explanation and elaboration: recommendations for enhancing the reporting and usefulness of paediatric randomised trial protocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
JAMA Pediatrics|February 24, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 Extension Statement: Enhancing the Reporting and Usefulness of Pediatric Randomized Trial ProtocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
Orphanet Journal of Rare Diseases|January 16, 2020
Outcomes in pediatric studies of medium-chain acyl-coA dehydrogenase (MCAD) deficiency and phenylketonuria (PKU): a reviewMichael Pugliese, Kylie Tingley, Andrea Chow, et al.
Pageof 25

Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
Journal of Clinical Epidemiology|May 10, 2026
Updating the PRISMA reporting guideline for scoping reviews: a scoping reviewAndrea C Tricco, Emily Robinson, Sharon E Straus, et al.
BMJ (Clinical Research Ed.)|February 24, 2026
CONSORT-C 2026 explanation and elaboration: recommendations for enhancing the reporting and impact of paediatric randomised trialsAmi Baba, Maureen Smith, Beth K Potter, et al.
BMJ (Clinical Research Ed.)|February 24, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
JAMA Pediatrics|February 24, 2026
CONSORT-Children and Adolescents (CONSORT-C) 2026 Extension Statement: Enhancing the Reporting and Impact of Pediatric Randomized TrialsAmi Baba, Maureen Smith, Beth K Potter, et al.
Plos One|June 14, 2014
The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial--BARTrialChristian V Hulzebos, Peter H Dijk, Deirdre E van Imhoff, et al.
The Lancet. Child & Adolescent Health|June 12, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
The New England Journal of Medicine|February 6, 2020
Lower versus Traditional Treatment Threshold for Neonatal HypoglycemiaAnne A M W van Kempen, P Frank Eskes, Debbie H G M Nuytemans, et al.
BMJ (Clinical Research Ed.)|February 24, 2026
SPIRIT-C 2026 explanation and elaboration: recommendations for enhancing the reporting and usefulness of paediatric randomised trial protocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
JAMA Pediatrics|February 24, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 Extension Statement: Enhancing the Reporting and Usefulness of Pediatric Randomized Trial ProtocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
Orphanet Journal of Rare Diseases|January 16, 2020
Outcomes in pediatric studies of medium-chain acyl-coA dehydrogenase (MCAD) deficiency and phenylketonuria (PKU): a reviewMichael Pugliese, Kylie Tingley, Andrea Chow, et al.
Pageof 25